banner
GLENMARK.NS image

Glenmark Pharmaceuticals Limited

GLENMARK.NS

1441

INR
+23.60
(+1.67%)
Day's range
1407.1
1449.7
52 wk Range
985.2
1830.95

GLENMARK.NS Cash Flow

Period EndingMar 31, 2024Mar 31, 2023Mar 31, 2022Mar 31, 2021Mar 31, 2020Mar 31, 2019Mar 31, 2018Mar 31, 2017Mar 31, 2016Mar 31, 2015Mar 31, 2014Mar 31, 2013Mar 31, 2012Mar 31, 2011Mar 31, 2010Mar 31, 2009Mar 31, 2008Mar 31, 2007Mar 31, 2006Mar 31, 2005Mar 31, 2004
Net Income-15,016,680,0008,684,510,00014,412,460,00013,824,750,00010,960,760,00013,006,290,00010,667,950,00012,601,520,00010,047,450,0005,942,830,0006,968,760,0007,390,050,0004,880,910,0004,815,530,0003,838,974,0002,688,813,0007,114,988,0003,613,183,0001,120,716,0001,272,942,000514,230,000
Depreciation & Amortization6,308,100,0006,112,680,0004,867,150,0004,435,540,0004,171,660,0003,259,050,0003,540,670,0005,765,200,0002,691,420,0002,599,800,0002,167,950,0001,270,090,000978,780,000946,780,0001,206,104,0001,034,249,000724,712,000442,591,000232,344,000164,232,000110,930,000
Deferred Income Tax0000000000486,470,00001,225,790,00000000000
Stock-Based Compensation49,620,00067,740,00079,160,00079,390,00030,840,0001,070,00090,640,000003,080,000-4,690,00011,560,00063,980,00082,710,0000000-311,000-1,202,000-4,593,000
Change in Working Capital-7,969,530,000-10,744,810,000-5,612,610,000-3,858,380,0001,270,640,0001,363,410,0003,090,600,000-8,615,130,000-6,077,090,000-2,673,090,000-2,900,740,000-2,530,040,000-347,930,0003,531,300,000-2,093,575,000-3,876,639,000-3,845,592,000-3,262,711,000-1,656,898,000-1,279,390,000-431,675,000
Accounts Receivable Change9,695,090,000-8,487,440,000-5,492,670,000-1,179,030,000-2,926,790,000444,310,0001,032,110,000171,570,000994,230,000-4,009,970,000-4,594,750,000-4,402,720,00003,011,770,0000000000
Inventory Change-5,138,580,000-3,751,690,000-2,034,190,000-1,338,080,000972,560,000-4,287,020,0001,352,970,000-6,143,150,000-4,338,970,000-3,544,300,000-511,920,000-435,980,00000-782,338,000-2,294,862,000-1,310,299,0002,140,924,000-381,090,000-372,614,000-377,230,000
Accounts Payable Change-7,344,140,0001,662,050,000847,570,0001,604,700,0001,527,360,0004,494,680,0002,008,130,000284,530,000-251,450,00000002,443,390,0000000000
Other Working Capital Change-5,181,900,000-167,730,0001,066,680,000-2,945,970,0001,697,510,000711,440,000-1,302,610,000-2,928,080,000-2,480,900,0004,881,180,0002,205,930,0002,308,660,000-347,930,000-1,923,860,000-1,311,237,000-1,581,777,000-2,535,293,000-5,403,635,000-1,275,808,000-906,776,000-54,445,000
Other Non-Cash Items13,974,050,0002,133,800,000-2,659,640,000-3,169,170,000-2,509,770,000-4,388,110,000-909,320,000-3,177,270,000-3,213,300,000-1,055,870,0001,819,500,000337,600,0001,242,380,000-73,710,000572,518,000312,658,000-276,276,000139,348,00035,798,000-12,511,00044,735,000
Net Cash Provided by Operating Activities-2,654,440,0006,253,920,00011,086,520,00011,312,130,00013,924,130,00013,241,710,00016,480,540,0006,574,320,0003,448,480,0004,816,750,0008,537,250,0006,479,260,0008,043,910,0009,302,610,0003,524,021,000159,081,0003,717,832,000932,411,000-268,351,000144,071,000233,627,000
Investments in Property, Plant & Equipment-8,983,780,000-6,077,630,000-7,901,170,000-7,747,580,000-9,313,730,000-12,371,710,000-10,446,400,000-7,485,290,000-8,902,720,000-5,442,750,000-3,766,250,000-4,709,610,000-2,853,960,000-4,011,600,000-3,958,007,000-9,744,522,000-5,227,573,000-2,797,043,000-2,621,314,000-2,048,036,000-656,574,000
Net Acquisitions54,496,090,000803,470,000112,520,000006,218,890,0000000000000000152,800,0000
Purchases of Investments0-60,080,000-400,180,00000-150,000,0000000000000-934,0000-44,871,000-4,661,000-1,178,000
Sales & Maturities of Investments70,510,00050,000,000300,000,000050,000,00085,550,0000000000006,942,00009,751,000036,0000
Other Investing Activities-145,520,000-670,0004,556,030,000995,220,0001,428,560,000-772,660,000312,970,000361,840,000101,010,00042,380,00085,210,00069,050,00076,100,000342,100,00088,881,000235,976,000129,932,00099,477,00098,680,000-19,665,000252,337,000
Net Cash Used for Investing Activities45,437,300,000-5,284,910,000-3,332,800,000-6,752,360,000-7,835,170,000-6,989,930,000-10,133,430,000-7,123,450,000-8,801,710,000-5,400,370,000-3,681,040,000-4,640,560,000-2,777,860,000-3,669,500,000-3,869,126,000-9,501,604,000-5,098,575,000-2,687,815,000-2,567,505,000-1,919,526,000-405,415,000
Debt Repayment-31,683,670,0006,299,690,000-10,307,970,000189,670,000-1,977,630,000-3,692,910,000-2,898,830,0007,942,650,000109,760,0004,807,200,0002,046,370,0004,475,450,000-1,564,870,000-2,579,940,0001,388,723,0008,224,059,000468,240,0001,732,968,0002,942,024,0003,232,375,000-91,711,000
Common Stock Issued12,000,000010,118,540,00000002,640,0009,354,950,00020,340,000125,010,00064,860,00035,560,00040,860,0004,142,780,000350,586,0001,986,910,000311,343,0003,668,000102,380,000508,185,000
Common Stock Repurchased00000-318,850,000000000-327,000,000-232,250,0000000000
Dividends Paid-1,177,520,000-1,366,060,000-926,950,000-704,470,000-685,540,000-678,810,000-678,820,000-678,050,000-678,530,000-634,650,000-631,910,000-642,560,000-126,090,000-125,820,000-117,996,0000-200,907,000-102,247,000-179,590,000-83,446,000-76,224,000
Other Financing Activities-6,212,080,000-5,708,190,000-4,088,530,000-3,902,990,000-1,783,460,000-2,696,780,000-1,107,340,000-1,835,730,000-1,800,220,000-2,200,660,000-2,519,630,000-1,945,400,000-1,958,530,000-1,458,970,000-4,713,025,000-82,368,000-365,980,000-185,095,000-147,017,000-285,102,000-125,493,000
Net Cash Used/Provided by Financing Activities-39,061,270,000-774,560,000-5,204,910,000-4,417,790,000-4,446,630,000-7,387,350,000-4,684,990,0005,431,510,0006,985,960,0001,992,230,000-980,160,0001,952,350,000-3,613,930,000-4,356,120,000700,482,0008,492,277,0001,888,263,0001,756,969,0002,619,085,0002,966,207,000214,757,000
Effect of Forex Changes on Cash176,790,000123,870,000175,500,000136,220,00097,640,000-1,835,210,000107,800,000-2,889,950,000-698,870,000-1,719,250,000-1,979,910,000-939,960,000-400,080,000-364,100,000000000-7,413,000
Net Change in Cash2,152,440,000325,000,0002,724,310,000278,200,0001,739,970,000-2,970,780,0001,769,920,0001,992,430,000933,860,000-310,640,0001,896,140,0002,851,090,0001,252,040,000912,890,000355,377,000-850,246,000507,520,0001,565,000-216,771,0001,191,500,00035,556,000
Cash at End of Period16,582,700,00014,430,260,00014,105,260,00011,380,950,00011,102,750,0009,362,780,00012,333,560,00010,563,640,0008,571,210,0007,637,350,0007,947,990,0006,051,850,0003,200,760,0001,948,720,0001,070,200,000714,823,0001,565,069,0001,057,549,0001,055,984,0001,272,755,00081,255,000
Cash at Beginning of Period14,430,260,00014,105,260,00011,380,950,00011,102,750,0009,362,780,00012,333,560,00010,563,640,0008,571,210,0007,637,350,0007,947,990,0006,051,850,0003,200,760,0001,948,720,0001,035,830,000714,823,0001,565,069,0001,057,549,0001,055,984,0001,272,755,00081,255,00045,699,000
Operating Cash Flow-2,654,440,0006,253,920,00011,086,520,00011,312,130,00013,924,130,00013,241,710,00016,480,540,0006,574,320,0003,448,480,0004,816,750,0008,537,250,0006,479,260,0008,043,910,0009,302,610,0003,524,021,000159,081,0003,717,832,000932,411,000-268,351,000144,071,000233,627,000
Capital Expenditure-8,983,780,000-6,077,630,000-7,901,170,000-7,747,580,000-9,313,730,000-12,371,710,000-10,446,400,000-7,485,290,000-8,902,720,000-5,442,750,000-3,766,250,000-4,709,610,000-2,853,960,000-4,011,600,000-3,958,007,000-9,744,522,000-5,227,573,000-2,797,043,000-2,621,314,000-2,048,036,000-656,574,000
Free Cash Flow-11,638,220,000176,290,0003,185,350,0003,564,550,0004,610,400,000870,000,0006,034,140,000-910,970,000-5,454,240,000-626,000,0004,771,000,0001,769,650,0005,189,950,0005,291,010,000-433,986,000-9,585,441,000-1,509,741,000-1,864,632,000-2,889,665,000-1,903,965,000-422,947,000